DexCom expects CONNECT study on type 2 diabetes to be published soon in a major journal.

At the 2026 Wells Fargo Healthcare Conference, DexCom's CFO Jereme Sylvain discussed the positive results from the CONNECT study on type 2 non-insulin diabetes. The company is preparing multiple filings related to CONNECT and conducting follow-up studies. They anticipate the study will be published soon in a major medical journal, although the exact timing and journal name are not disclosed due to publication protocols. This publication could enhance DexCom's profile in diabetes care innovation.